Because angiogenesis is a defining hallmark of tumor growth and metastatic progression, any therapeutic agent that enhances neovascularization could, in theory, facilitate tumor expansion and promote metastatic dissemination
Arai M, Imai H, Koumura T, Yoshida M, Emoto K, Umeda M et al
Regulatory status further limits clinical use, since BPC-157 is not approved for medical treatment and available data remains largely experimental
For individuals with pattern hair loss driven by DHT sensitivity, this represents a significant advantage
Without comprehensive clinical data, it is impossible to predict or manage these risks effectively
Many people report feeling more energised and focused within a few days, although results can vary depending on individual needs